首页> 美国卫生研究院文献>Oncotarget >Loss of maternal chromosome 11 is a signature event in SDHAF2 SDHD and VHL-related paragangliomas but less significant in SDHB-related paragangliomas
【2h】

Loss of maternal chromosome 11 is a signature event in SDHAF2 SDHD and VHL-related paragangliomas but less significant in SDHB-related paragangliomas

机译:孕妇染色体11丢失是SDHAF2SDHD和VHL相关副神经节瘤中的一个标志性事件但在SDHB相关副神经节瘤中不那么重要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Germline mutations in the succinate dehydrogenase (SDHA, SDHB, SDHC, SDHD, SDHAF2) or Von Hippel-Lindau (VHL) genes cause hereditary paraganglioma/pheochromocytoma. While SDHB (1p36) and VHL (3p25) are associated with autosomal dominant disease, SDHD (11q23) and SDHAF2 (11q13) show a remarkable parent-of-origin effect whereby tumor formation is almost completely dependent on paternal transmission of the mutant allele. Loss of the entire maternal copy of chromosome 11 occurs frequently in SDHD-linked tumors, and has been suggested to be the basis for this typical inheritance pattern.Using fluorescent in situ hybridization, microsatellite marker and SNP array analysis, we demonstrate that loss of the entire copy of chromosome 11 is also frequent in SDHAF2-related PGLs, occurring in 89% of tumors. Analysis of two imprinted differentially methylated regions (DMR) in 11p15, H19-DMR and KvDMR, showed that this loss always affected the maternal copy of chromosome 11. Likewise, loss of maternal chromosome 11p15 was demonstrated in 85% of SDHD and 75% of VHL-related PGLs/PCCs. By contrast, both copies of chromosome 11 were found to be retained in 62% of SDHB-mutated PGLs/PCCs, while only 31% showed loss of maternal chromosome 11p15. Genome-wide copy number analysis revealed frequent loss of 1p in SDHB mutant tumors and show greater genomic instability compared to SDHD and SDHAF2.These results show that loss of the entire copy of maternal chromosome 11 is a highly specific and statistically significant event in SDHAF2, SDHD and VHL-related PGLs/PCCs, but is less significant in SDHB-mutated tumors, suggesting that these tumors have a distinct genetic etiology.
机译:琥珀酸脱氢酶(SDHA,SDHB,SDHC,SDHD,SDHAF2)或冯·希佩尔·林道(VHL)基因中的种系突变导致遗传性副神经节瘤/嗜铬细胞瘤。 SDHB(1p36)和VHL(3p25)与常染色体显性疾病有关,而SDHD(11q23)和SDHAF2(11q13)显示出显着的原产地效应,因此肿瘤的形成几乎完全取决于突变体等位基因的父本传播。在SDHD连锁肿瘤中,母本11号染色体整个拷贝的丢失经常发生,并被认为是这种典型遗传模式的基础。利用荧光原位杂交,微卫星标记和SNP阵列分析,我们证明了11号染色体的丢失。在SDHAF2相关的PGL中,染色体11的整个拷贝也很常见,发生在89%的肿瘤中。对11p15中两个印迹差异甲基化区域(DMR),H19-DMR和KvDMR的分析表明,这种丢失始终会影响11号染色体的母本拷贝。同样,在85%的SDHD和75%的SDHD中证明了11p15母本染色体的丢失。 VHL相关的PGL / PCC。相比之下,发现11号染色体的两个副本都保留在62%的SDHB突变PGL / PCC中,而只有31%的染色体显示出母体11p15丢失。全基因组拷贝数分析表明,与SDHD和SDHAF2相比,SDHB突变型肿瘤频繁丢失1p并显示出更大的基因组不稳定性。这些结果表明,母体第11号染色体整个拷贝的丢失是SDHAF2中高度特异性且具有统计学意义的事件, SDHD和VHL相关的PGL / PCC,但在SDHB突变的肿瘤中意义不大,这表明这些肿瘤具有独特的遗传病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号